Antibiotics May Boost Risk for Recurrent Ear Infection
... Researchers urge more temperate prescribing of amoxicillin in kids,,,, WEDNESDAY, July 1 (HealthD...d that 63 percent of children given the antibiotic amoxicillin experienced a recurrent ear infection within three...mes higher risk of recurrent ear infection for the amoxicillin group. However, the study also found that 30 pe...Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results
...certain existing products. Products which experienced significant volume and pricing declines included fluticasone, propranolol, cabergoline, various amoxicillin products, ranitidine syrup, tramadol HCl and acetaminophen tablets driven by Par's exit from the market, and lower royalty payments of ondansetron tab...MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009
... The first and only FDA-approved once-daily amoxicillin will be promoted to health care professionals nati...proval for Moxatag - the first and only once-daily amoxicillin product approved for marketing in the U.S. For mo...g, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
...ed-release) Tablets, 775mg, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three components: one immediate-relea...nents of Moxatag are combined in a specific ratio to prolong the release of amoxicillin compared to immediate-release amoxicillin. Moxatag is intended to provide ...MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
...atag -- the first and only FDA-approved once-daily amoxicillin -- in first quarter 2009," Thievon continued. Th...g, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...ined in a specific ratio to prolong the release of amoxicillin compared to immediate-release amoxicillin. Moxatag...An ideal therapy for peptic ulcer disease
...had to withdraw from the treatment due to the presence of severe adverse effect. Their result indicated that the association of bismuth, furazolidone, amoxicillin and a proton-pump inhibitor is a valuable alternative for peptic ulcer patients. ...MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
...g, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...ined in a specific ratio to prolong the release of amoxicillin from Moxatag compared to immediate-release amoxici...roval for Moxatag -- the first and only once-daily amoxicillin product approved for marketing in the U.S. For mor...Par Pharmaceutical Reports Third Quarter 2008 Results
...wer generic revenues in 2008 were primarily due to pricing pressure, including for metoprolol, fluticasone, propranolol, ranitidine HCl syrup, various amoxicillin products, cabergoline, and many of the Company's other products. The July 2008 launches of meclizine and dronabinol partially offsetting these decline...MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
...the advantages of MOXATAG over currently available amoxicillin therapies with healthcare practitioners across the...s are a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...ined in a specific ratio to prolong the release of amoxicillin from MOXATAG compared to immediate-release amoxici...Allsup Introduces Health Discount Program to Millions of People with Disabilities
...rm care and alternative care services. Examples of potential savings include: a $72 savings on a $235 doctor's office visit; $5.40 savings on a $12.90 amoxicillin prescription; $26 savings on a $70 dental cleaning; and $17 savings on a $57 eye exam. "We know from speaking with people with disabilities t...FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Amoxicillin PULSYS to be Marketed as MOXATAG(TM) - First Once-Daily Amoxicillin Product Approved in U.S. GERMANTOWN, Md., Jan. 24 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company focused on developing and commercializing ...Penicillin, amoxicillin: Step aside for strep throat treatment
...long-time antibiotic stalwarts like penicillin and amoxicillin to step aside when it comes to the treatment of st...in three weeks of treatment. Children treated with amoxicillin returned 18 percent of the time. The numbers were ...wn as Keflex) cost about the same as penicillin or amoxicillin but are more effective against strep. Nearly al...Gaining ground in the race against antibiotic resistance
...e alpha-lactam ring in half, inactivating the drugs. An inhibitor for one type of lactamase has already been marketed as part of a 'package drug' with amoxicillin to fight resistance. But the lactamase enzyme that Vila's group studied is in a different class that is causing an emerging problem around the worl...MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
...g, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...ined in a specific ratio to prolong the release of amoxicillin compared to immediate-release amoxicillin. Moxata...y alternative to currently approved penicillin and amoxicillin regimens for the treatment of adults and pediatric...MiddleBrook Hires TalenTactics to Recruit National Field Force
...s are a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...ined in a specific ratio to prolong the release of amoxicillin from MOXATAG compared to immediate-release amoxici...y alternative to currently approved penicillin and amoxicillin regimens for the treatment of adults and pediatric...Par Pharmaceutical Reports Second Quarter 2008 Results
...offsetting the decreases were increased sales of metoprolol resulting from the launch of additional strengths in the third quarter of 2007 and various amoxicillin products. Second quarter 2008 revenue for Strativa decreased to $20.0 million from $21.6 million in the prior year due to decreased net sales of Megac...MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
... The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily amoxicillin product approved for marketing in the U.S. For more on MiddleBrook, please visit http://www.middlebrookpharma.com . ...MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
...ny's New Drug Application (NDA) for its once-daily amoxicillin PULSYS(R) product, under the trade name, MOXATAG(T...al for MOXATAG(TM) - the first and only once-daily amoxicillin product approved for marketing in the U.S. For mor...s are a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three compon...MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
... The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily amoxicillin product approved for marketing in the U.S. For more on MiddleBrook, please visit http://www.middlebrookpharma.com . ...MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
...rom the financing to support the manufacture of MOXATAG(TM), its once-daily amoxicillin product, and for working capital and general corporate purposes. The shar...ceived regulatory approval for MOXATAG(TM) -- the first and only once-daily amoxicillin product approved for marketing in the U.S. For more on MiddleBrook, please ...